...
【24h】

False-Negative NIPT Result for Trisomy 21

机译:Trisomy 21的假阴性效果结果

获取原文
获取原文并翻译 | 示例

摘要

The determination of fetal cell-free DNA in the mother’s blood in screening for aneuploidy has a big influence in prenatal medicine. The term, “noninvasive prenatal testing (NIPT)”, suggests to the pregnant woman that the test is “non-hazardous”. NIPT, which is a valuable screening method, has become a competitor to first-trimester screening.NIPT has a detection rate for trisomy 21, 18 and 13 of up to 99 %, 90 % and 89 %, respectively, with a very low false-positive rate [1] [2]. Medical societies such as DEGUM [3] [4] and the International Society of Ultrasound in Obstetrics and Gynecology [5] [6] have recently published recommendations stating that a pregnant woman should only be offered an NIPT test after undergoing a proper first-trimester ultrasound examination.We report a case of a false-negative NIPT result to emphasize once again the importance of fetal ultrasound.The 40-year-old woman, 3G 1P (height 165 cm, weight 69.1 kg, body mass index 25.4) decided because of her age to have an NIPT Harmony Test (Cenata) in the 12 + 1 gestational week. The physician took blood without first referring the woman to an ultrasound specialist (level II or III). The result was inconspicuous, with the following values: “Fetal proportion of the cell-free DNA 14.7 %, trisomy 21 < 0.01 %, trisomy 18 < 0.01 %, trisomy 13 < 0.01 % and genotype for sex chromosomes XX, risk X-/Y- chromosomal abnormality inconspicuous, sex of fetus female.”At 21 gestational weeks, the patient was referred for second-trimester screening (DEGUM Level II). The diagnosis of an atrioventricular defect (AVSD) was made. In addition, the fetus had brachycephaly, a shortened humerus and femur and polyhydramnios. The recommended amniocentesis confirmed trisomy 21 (47,XX,+ 21). Following counselling, the patient decided to have the child. In the 38th week of pregnancy the girl was born with the typical Down syndrome features and the cardiac defect. The correction of the heart defect is intended for the fifth month.While the NIPT is a high-grade “screening method” in the search for certain chromosomal abnormalities, it cannot be equated with a “diagnostic test” [7] [8]. This case shows why medical societies such as DEGUM, ?GUM and SGUM recommend that a precondition for an NIPT is always a proper ultrasound examination satisfying DEGUM II/III.
机译:在母血液中筛选胎儿血液中的胎儿细胞DNA的测定对动脉倍增性具有很大的影响。 “非侵入性产前检测(NIPT)”术语表明,该测试是测试是“非危险”的孕妇。 NIPT是一种有价值的筛查方法,已成为竞争对手的孕孕筛选。目的分别具有三元体21,18和13的检出率,分别具有高达99%,90%和89%,具有非常低的假 - 积分率[1] [2]。医学社团如Degum [3] [4]和妇产科的国际超声社会[5] [5]超声检查。我们报告了一个假阴性效果的案例,再次强调胎儿超声的重要性。40岁的女性,3G 1P(高度165厘米,重量69.1公斤,体重指数25.4)决定是因为她的年龄在12 + 1个妊娠周内有一个nipt和谐测试(Cenata)。医生在没有先将女性推荐给超声专家(第II级或III)的情况下服用血液。结果不显眼,具有以下值:“无细胞DNA的胎儿比例14.7%,三兆癣21 <0.01%,三兆癣18 <0.01%,三元13 <0.01%和性染色体的基因型,风险X- / Y-染色体异常不明显,胎儿性别的女性。“在21个妊娠周,患者被提到第二孕孕酮筛选(抗体II)。制造了房室缺陷(AVSD)的诊断。此外,胎儿患有Brachycephaly,缩短的肱骨和股骨和多福利。推荐的羊膜穿刺术证实了三胞结构21(47,XX,+ 21)。咨询后,患者决定让孩子。在怀孕的第38周,女孩诞生于典型的唐氏综合征特征和心脏缺陷。心脏缺陷的校正适用于第五个月。当NIPT是在寻找某些染色体异常的高档“筛选方法”时,它不能等同于“诊断测试”[7] [8]。本例表明了为什么医学社团如DEGUM,?GUM和SGUM建议NIPT的前提是一个适当的超声检查,满足DEGUM II / III。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号